US: Ohio Appeals Court Backs Local Tobacco Control: Strikes Down State Law Limiting City Regulations

Jul.10.2025
US: Ohio Appeals Court Backs Local Tobacco Control: Strikes Down State Law Limiting City Regulations
An Ohio appeals court has struck down a state law that blocked local governments from enacting tobacco regulations, ruling that cities can govern tobacco under their home-rule authority. The state legislature had previously overridden the governor’s veto of the law. The decision bolsters local efforts to address public health challenges through independent tobacco control measures.

Key Points:

 

·The Ohio Court of Appeals in the United States has ruled that cities have the right to autonomously regulate tobacco, overturning related state laws. 

 

·Previously, the state legislature twice overturned the governor's veto on bills prohibiting local regulation of tobacco. 

 

·The ruling supports cities to establish tobacco regulations based on their autonomy, such as banning flavored tobacco. 

 


【2Firsts News Flash】According to a report by 10Wbns on July 9th, the Ohio Court of Appeals in the United States made a ruling supporting local cities to develop tobacco regulations according to their own needs, and overturned a state law that should have prevented local governments from establishing local tobacco regulations. This ruling is a significant response to the dispute over jurisdiction in public health.

 

This ruling was made by the Ohio Tenth District Court of Appeals, with the case initially being handled by the Franklin County Common Pleas Court. It is worth noting that the law at the center of the dispute - Revised Code 9.681 - has been vetoed twice by Governor Mike DeWine. This law grants the state government comprehensive regulatory authority over tobacco and alternative nicotine products, aimed at prohibiting local governments from creating independent rules.

 

Governor Devan emphasized that the ban on flavored tobacco and nicotine alternative products by local governments is a key tool in combating addiction issues - although he prefers a statewide comprehensive ban, covering all flavored tobacco products, including mint.

 

 

What does this ruling mean?

 

If Article 9.681 of the Revised Code is ultimately passed, it will immediately repeal all local tobacco regulations. For example, in Columbus, the legislation would revoke:

 

·Ban on the sale of flavored tobacco products; 

·Authority to issue and manage business licenses for tobacco retailers; 

·Compliance checks conducted by the Columbus Public Health Department (to prevent sales to individuals under 21 years of age).

 

However, the court ultimately ruled in support of the decision of the Franklin County Court, believing that the ordinance passed by the city of Columbus falls under the city's "police power" and is a reasonable action for the purpose of public safety. At the same time, the court found that Section 9.681 of the Revised Code did not constitute a substantive tobacco regulation ordinance, therefore it was not sufficient to supplant the legislative authority of local governments.

 

This means that multiple cities will be able to continue enforcing their own flavored tobacco bans in response to local public health issues.

 

 

A Protracted Political and Legal Battle

 

The origins of this controversy can be traced back to December 2022. At that time, the Columbus City Council passed an ordinance authorizing the city's public health department to enforce the city's tobacco laws and health code. The ordinance established a comprehensive system of penalties for violations, including fines, license revocation, and explicitly prohibited the sale of flavored tobacco products.

 

It is worth noting that the regulation clearly states that flavored tobacco products poses disproportionately higher health risks for certain groups, such as African American smokers.

 

Columbus' actions triggered a chain reaction, with multiple cities subsequently passing similar regulations. Cities participating in the joint lawsuit include Columbus, Athens, Barberton, Bexley, Cincinnati, Cleveland, Dublin, Gahanna, Grandview Heights, Heath, Hilliard, Kent, North Ridgeville, Oberlin, Oxford, Reynoldsburg, Springfield, Toledo, Upper Arlington, Whitehall, and Worthington.

 

However, just two days after the City of Columbus passed a tobacco ordinance, the Ohio Senate Finance Committee quickly amended House Bill 513, adding provisions to prohibit all local tobacco regulation ordinances under Revised Code 9.681. The amendment was passed by the legislature on the same day.

 

Despite Governor Devan exercising his veto power again in January 2023, citing concerns that increased tobacco use would lead to higher medical expenses for taxpayers, by the end of the year, the state legislature had twice overridden Devan's veto and passed Amendment 9.681.

 

 

Constitutional Basis of Local Autonomy

 

The core of this legal battle is a dispute over the interpretation of Article 18, Section 3 of the Ohio State Constitution. This provision clearly grants cities wide-ranging local autonomy, particularly in the ability to establish and enforce local rules on issues such as public safety and health, as long as they do not conflict with state law.

 

In terms of cities, it has been pointed out that the state law prohibiting local regulation of tobacco has violated local autonomy and goes against the spirit of the constitution.

 

Columbus City Prosecutor Zach Klein stated in a declaration, "This ruling is a significant victory, reaffirming a fundamental principle in our state constitution - cities have the right to determine what policies best serve the health and safety interests of local residents.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
Product | JNR Launches Shisha Hookah 70K E-Hookah With 60ml E-Liquid and 0.6% Nicotine
JNR has introduced the Shisha Hookah 70K, a high-capacity rechargeable disposable vape designed around a hookah-inspired experience. The device comes prefilled with 60ml of e-liquid at 6mg/ml (0.6%) nicotine strength, alongside a 1,000mAh rechargeable battery and a 0.38Ω single mesh coil. It also features adjustable airflow and battery and e-liquid level displays. JNR claims the device can deliver up to 70,000 puffs and offers more than 20 flavors. Retail listings for the product have appeared in markets including Tunisia.
Market
Aug.24 by 2Firsts Perspectives
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
IQOS Global Flagship Space to Open in Tokyo Ginza as PMI Expands Consumer Experience Strategy
Philip Morris Japan (PMJ) announced that it will open “IQOS Flagship Ginza” in Tokyo on September 4, 2026. The location will become the first global flagship space for PMI’s IQOS brand. PMJ said the venue will target adult smokers aged 20 and above and combine product experiences, community engagement and local cultural elements. The design will incorporate Japanese natural aesthetics and traditional craftsmanship. The launch reflects PMI’s broader strategy of strengthening consumer engagement through experiential retail and brand spaces. The existing IQOS Store Ginza is scheduled to close on August 30, 2026.
Jul.21
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
Product | FOGER Introduces Switch Pro 30K Nixodine Pod in U.S. Retail, Bringing 6-MN Related Formulation to High-Capacity Pod Platform
FOGER has introduced the Switch Pro 30K Nixodine Pod in U.S. retail channels, bringing a 6-methylnicotine (6-MN)-related formulation into its reusable Switch Pro 30K pod ecosystem. The product retains the existing reusable dock and magnetic replacement pod architecture, featuring a 19ml prefilled pod, dual-mesh heating and Normal/Boost modes. The Nixodine version is labeled nicotine-free in terms of conventional nicotine but uses a 5% Nixodine-related formulation. The product has appeared in U.S. retail and wholesale channels, with some listings indicating Kentucky-only availability.
Aug.28
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore Seeks to Toss CCELL Price-Fixing Claim as Court Weighs Vertical Distribution Versus Horizontal Conspiracy
Smoore and four authorized U.S. CCELL distributors are asking a California federal court to permanently dismiss a core antitrust claim brought by direct purchasers. Plaintiffs allege that Smoore coordinated minimum wholesale prices, customer allocation and limits on price competition among distributors, amounting to a per se unlawful horizontal conspiracy. The defendants say the alleged conduct reflects ordinary vertical relationships between a manufacturer and its distributors. The court previously dismissed a similar claim, and the latest dispute centers on whether the second amended complaint adds sufficient facts to establish a horizontal agreement.
Sep.14
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
Product | R.J. Reynolds Launches Four Flavored Vuse Pro Pods for Vuse Alto Devices in U.S.
R.J. Reynolds Vapor Company has introduced Vuse Pro prefilled pods in Peach, Berry, Watermelon and Fresh Mint in selected U.S. states. Vuse’s U.S. website says the pods are intended for use with existing Vuse Alto devices. Each contains 2.0 mL of e-liquid at 5.0% nicotine by weight, uses nicotine salts and is offered in two- and four-pod packs. Reynolds said the rollout includes mandatory ID scanning for every purchase, purchase limits, stronger retailer-accountability requirements and strict age-restricted marketing standards. The four pods have not received marketing authorization from the U.S. Food and Drug Administration.
Sep.10